Kevin Corcoran has become vice president of software at Pacific Biosciences. Prior to joining PacBio, he was vice president and general manager of genetic analysis at Applied Biosystems. Corcoran holds a BS in computer science from California State University, Hayward.
Mel Kronick, Bernard Daugeras, Stephane Mery, Mark Treherne, Sam Eletr, Anthony Salerno, Jonathan Eisen, Kevin Corcoran
Mel Kronick has become CEO of Population Genetics Technologies and has joined the company’s board of directors. Kronick is a former division R&D manager of Agilent Technologies and of Applied Biosystems, where he was involved in the development of products related to DNA sequencing and microarray technology.
Further board members include Bernard Daugeras, a managing partner of Auriga Partners; Stephane Mery, director of healthcare investments at Noble Fund Managers; and Mark Treherne, a former research executive at Pfizer.
Sam Eletr, former acting CEO of PGT, is now chairman of the board, taking the role over from Treherne. He is a founder of Applied Biosystems and Lynx Therapeutics.
Anthony Salerno has become vice president of strategic business development of GenomeQuest. He will be responsible for guiding the company’s entry into the next-generation DNA sequencing bioinformatics market. Most recently, Salerno was director of strategic business development at Agilent Technologies. Salerno holds a BA degree from the College of the Holy Cross and studied biochemistry and molecular biology in the Graduate School of Arts and Sciences of Harvard University.
Jonathan Eisen has become the first academic editor-in-chief of PLoS Biology. He is a professor at the University of California Davis Genome Center.